BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12682877)

  • 1. Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new.
    Tefferi A
    Semin Hematol; 2003 Jan; 40(1 Suppl 1):18-21. PubMed ID: 12682877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelofibrosis with myeloid metaplasia: therapeutic options in 2003.
    Mesa RA
    Curr Hematol Rep; 2003 May; 2(3):264-70. PubMed ID: 12901349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.
    Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A
    Best Pract Res Clin Haematol; 2006; 19(3):495-517. PubMed ID: 16781486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches in the treatment of myelofibrosis.
    Hennessy BT; Thomas DA; Giles FJ; Kantarjian H; Verstovsek S
    Cancer; 2005 Jan; 103(1):32-43. PubMed ID: 15565565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern management of myelofibrosis.
    Cervantes F
    Br J Haematol; 2005 Mar; 128(5):583-92. PubMed ID: 15725078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment.
    Dingli D; Mesa RA; Tefferi A
    Intern Med; 2004 Jul; 43(7):540-7. PubMed ID: 15335177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and old treatment modalities in primary myelofibrosis.
    Cervantes F; Mesa R; Barosi G
    Cancer J; 2007; 13(6):377-83. PubMed ID: 18032975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and current practice in treatment of myelofibrosis with myeloid metaplasia: an update anno 2000.
    Cervantes F
    Pathol Biol (Paris); 2001 Mar; 49(2):148-52. PubMed ID: 11317960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the pathogenesis and drug treatment of myelofibrosis.
    Tefferi A
    Curr Opin Hematol; 2006 Mar; 13(2):87-92. PubMed ID: 16456374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide for the treatment of idiopathic myelofibrosis.
    Strupp C; Germing U; Scherer A; Kündgen A; Mödder U; Gattermann N; Haas R
    Eur J Haematol; 2004 Jan; 72(1):52-7. PubMed ID: 14962263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide therapy for myelofibrosis with myeloid metaplasia.
    Thomas DA; Giles FJ; Albitar M; Cortes JE; Verstovsek S; Faderl S; O'Brien SM; Garcia-Manero G; Keating MJ; Pierce S; Zeldis J; Kantarjian HM
    Cancer; 2006 May; 106(9):1974-84. PubMed ID: 16583431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The forgotten myeloproliferative disorder: myeloid metaplasia.
    Tefferi A
    Oncologist; 2003; 8(3):225-31. PubMed ID: 12773744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A
    J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelofibrosis with myeloid metaplasia: diagnosis, prognostic factors, and staging.
    Cervantes F; Barosi G
    Semin Oncol; 2005 Aug; 32(4):395-402. PubMed ID: 16202685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
    Abgrall JF; Guibaud I; Bastie JN; Flesch M; Rossi JF; Lacotte-Thierry L; Boyer F; Casassus P; Slama B; Berthou C; Rodon P; Leporrier M; Villemagne B; Himberlin C; Ghomari K; Larosa F; Rollot F; Dugay J; Allard C; Maigre M; Isnard F; Zerbib R; Cauvin JM;
    Haematologica; 2006 Aug; 91(8):1027-32. PubMed ID: 16885042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapy of myelofibrosis: targeting pathogenesis.
    Mesa RA
    Int J Hematol; 2002 Aug; 76 Suppl 2():296-304. PubMed ID: 12430941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for myelofibrosis.
    van Besien K; Deeg HJ
    Semin Oncol; 2005 Aug; 32(4):414-21. PubMed ID: 16202687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.